Literature DB >> 16137228

Basic fibroblast growth factor activates ERK and induces c-fos in human embryonic stem cell line MizhES1.

Ho Bum Kang1, Jin Sook Kim, Hyung-Joo Kwon, Ki Hoan Nam, Hyun Soo Youn, Dai-Eun Sok, Younghee Lee.   

Abstract

Human embryonic stem (hES) cells can be maintained in a proliferative undifferentiated state in vitro by growing them on feeder layers of mouse embryonic fibroblast (MEF) cells along with basic fibroblast growth factor (bFGF/FGF-2). To understand the molecular mechanisms involved in the requirement of bFGF in human ES cells, we investigated expression of FGF receptors and intracellular signaling events in response to bFGF in human ES cell line MizhES1. On the basis of the results of RT-PCR, clear expression of FGF receptors FGFR1, FGR2, and FGFR3 was noticed. Because MAPK, PI3K, and PKC pathways are well-known pathways triggered by bFGF in other cells, these pathways were investigated after stimulation with bFGF. bFGF did not induce activation of PI3K or PKC, but induced activation of ERK (extracellular signal-regulated kinase). To monitor the consequences of ERK activation, we examined expression of the immediate early gene c-fos, one downstream target of the MEK1/ERK pathway. mRNA and protein levels of the c-fos gene were increased by bFGF. Induction of c-Fos was dependent on MEKl. Therefore, it is likely that bFGF contributes to maintenance of human ES cells, at least in part, through the MEK1/ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137228     DOI: 10.1089/scd.2005.14.395

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  22 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 2.  Extrinsic regulation of pluripotent stem cells.

Authors:  Martin F Pera; Patrick P L Tam
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

3.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.

Authors:  Jianping Xie; Adetola Olalekan Ajibade; Fengchun Ye; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2007-10-26       Impact factor: 3.616

Review 4.  Pluripotent stem cell lines.

Authors:  Junying Yu; James A Thomson
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

Review 5.  Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency.

Authors:  Morag H Stewart; Sean C Bendall; Mickie Bhatia
Journal:  J Mol Med (Berl)       Date:  2008-06-03       Impact factor: 4.599

6.  Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.

Authors:  Emily G Farrow; Lelia J Summers; Susan C Schiavi; James A McCormick; David H Ellison; Kenneth E White
Journal:  J Endocrinol       Date:  2010-07-30       Impact factor: 4.286

7.  FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation.

Authors:  Pengzhi Yu; Guangjin Pan; Junying Yu; James A Thomson
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

8.  Effects of epidermal growth factor and basic fibroblast growth factor on the proliferation and osteogenic and neural differentiation of adipose-derived stem cells.

Authors:  Feihu Hu; Xiu Wang; Gaofeng Liang; Lanxin Lv; Yanliang Zhu; Bo Sun; Zhongdang Xiao
Journal:  Cell Reprogram       Date:  2013-06       Impact factor: 1.987

Review 9.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

10.  NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs.

Authors:  Ren-He Xu; Tori L Sampsell-Barron; Feng Gu; Sierra Root; Ruthann M Peck; Guangjin Pan; Junying Yu; Jessica Antosiewicz-Bourget; Shulan Tian; Ron Stewart; James A Thomson
Journal:  Cell Stem Cell       Date:  2008-08-07       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.